EWTX
Edgewise TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The May 7, 2026 update kept the two most important clinical milestones intact: Q2 2026 CIRRUS-HCM data and Q4 2026 GRAND CANYON pivotal Becker data. The filing also showed $499.6 million of cash, cash equivalents and marketable securities at March 31, 2026, while the 10-Q says existing liquidity should fund planned operating expenses and capital expenditures for at least the next 12 months [#10-Q-2026-05-07].
Posture
Constructive
Lead driver
Momentum
What changed
3 setup hits (3d) with net bullish as of 2026-06-03.
What can break
Clinical readouts in HCM or Becker could miss on efficacy, safety, or interpretability, which would pressure a pipeline-led valuation.
Momentum
80
Value
41
Sentiment
54
Setup hits (3d)
3 · Net Bullish
AI TargetsBase $40.00 · Bull $50.00 · Bear $24.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Bullish
Target $42.80
Why
Momentum80 · Δ7d +1.2
Value41 · Δ7d +0.1
Sentiment54 · Δ7d -19.9
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
80
34% active weight
Current posture
7d trendImproving
Δ7d
+1.2
Δ21d
-0.6
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
54
33% active weight
Current posture
7d trendSoftening
Δ7d
-19.9
Δ21d
-8.1
Why this grade
Composite grade B. Momentum 79.8 / Value 41.1 / Sentiment 53.6
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$4.01B
Beta
0.28
Shares Out
105.87M
P/E (TTM) · Derived
-23.2
P/S (TTM)
-
P/FCF (TTM) · Derived
-28.56
Rev YoY
-
EPS YoY
-6.0%
Gross Margin
-
Op Margin
-
Net Debt
-$470.17M
Current Ratio
26.51
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology